Boai NKY Medical Holdings Ltd. (SHE:300109)

Market Cap	9.17B +9.1%
Revenue (ttm)	1.20B -22.2%
Net Income	174.42M -43.5%
EPS	0.29 -44.8%
Shares Out	580.06M
PE Ratio	53.70
Forward PE	n/a
Dividend	0.17 (1.05%)
Ex-Dividend Date	Jun 23, 2026

Volume	10,271,188
Open	15.80
Previous Close	15.78
Day's Range	15.71 - 16.06
52-Week Range	13.33 - 17.59
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About Boai NKY Medical Holdings

Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP), Orarez, and in vitro diagnostic products, as well as invests in tumor drugs. It offers its products for pharmaceutical products, such as APIs and excipients; personal care products, including cosmetics, haircare, oral care, and household care; alcohol, soft drinks, and food; battery, petroleum and natural gas, and photovoltaic; and membrane, textile and dyeing, ag...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1987
• Employees: 1,186
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300109

Financial Performance

In 2025, Boai NKY Medical Holdings's revenue was 1.18 billion, a decrease of -26.66% compared to the previous year's 1.61 billion. Earnings were 190.09 million, a decrease of -45.64%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 3, 2026

Data Sources Report a data error